George Tokiwa
Merck & Co.
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by George Tokiwa.
Molecular Systems Biology | 2010
Julja Burchard; Chunsheng Zhang; Angela M. Liu; Ronnie Tung-Ping Poon; Nikki P. Lee; Kwong-Fai Wong; Pak Sham; Brian Yee Hong Lam; Mark Ferguson; George Tokiwa; Ryan Smith; Brendan Leeson; Rebecca Beard; John Lamb; Lee Lim; Mao Mao; Hongyue Dai; John M. Luk
Tumorigenesis involves multistep genetic alterations. To elucidate the microRNA (miRNA)–gene interaction network in carcinogenesis, we examined their genome‐wide expression profiles in 96 pairs of tumor/non‐tumor tissues from hepatocellular carcinoma (HCC). Comprehensive analysis of the coordinate expression of miRNAs and mRNAs reveals that miR‐122 is under‐expressed in HCC and that increased expression of miR‐122 seed‐matched genes leads to a loss of mitochondrial metabolic function. Furthermore, the miR‐122 secondary targets, which decrease in expression, are good prognostic markers for HCC. Transcriptome profiling data from additional 180 HCC and 40 liver cirrhotic patients in the same cohort were used to confirm the anti‐correlation of miR‐122 primary and secondary target gene sets. The HCC findings can be recapitulated in mouse liver by silencing miR‐122 with antagomir treatment followed by gene‐expression microarray analysis. In vitro miR‐122 data further provided a direct link between induction of miR‐122‐controlled genes and impairment of mitochondrial metabolism. In conclusion, miR‐122 regulates mitochondrial metabolism and its loss may be detrimental to sustaining critical liver function and contribute to morbidity and mortality of liver cancer patients.
Journal of Neuroscience Methods | 2004
Mark L Parrish; Nan Wei; Sven Duenwald; George Tokiwa; Yanqun Wang; Daniel J. Holder; Hongyue Dai; Xiaohua Zhang; Christopher Wright; Paul Hodor; Guy Cavet; Robert Phillips; Benjamin I Sun; Thomas L. Fare
To address the need for high sensitivity in gene expression profiling of small neural tissue samples ( approximately 100 ng total RNA), we compared a novel RT-PCR-IVT protocol using fluor-reverse pairs on inkjet oligonucleotide microarrays and an RT-IVT protocol using 33P labeling on nylon cDNA arrays. The comparison protocol was designed to evaluate these systems for sensitivity, specificity, reproducibility, and linearity. We developed parameters, thresholds, and testing conditions that could be used to differentiate various systems that spanned detection chemistry and instrumentation; probe number and selection criteria; and sample processing protocols. We concluded that the inkjet system had better performance in sensitivity, specificity, and reproducibility than the nylon system, and similar performance in linearity. Between these two platforms, the data indicates that the inkjet system would perform better for the transcriptional profiling of 100 ng total RNA samples for neuroscience studies.
Brain Research | 2009
Christopher J. Winrow; Keith Q. Tanis; Alison M. Rigby; Rhonda R. Taylor; Kyle Serikawa; Mollie McWhorter; George Tokiwa; Matthew J. Marton; David J. Stone; Kenneth S. Koblan; John J. Renger
Powerful new approaches to study molecular variation in distinct neuronal populations have recently been developed enabling a more precise investigation of the control of neural circuits involved in complex behaviors such as wake and sleep. We applied laser capture microdissection (LCM) to isolate precise brain nuclei from rat CNS at opposing circadian time points associated with wake and sleep. Discrete anatomical and temporal analysis was performed to examine the extent of variation in the transcriptional control associated with both identifiable anatomical nuclei and with light/dark cycle. Precise isolation of specific brain nuclei regulating sleep and arousal, including the LC, SCN, TMN, VTA, and VLPO, demonstrated robust changes in gene expression. Many of these differences were not observed in previous studies where whole brain lysates or gross dissections were used to probe for changes in gene expression. The robust and differential profiles of genomic data obtained from the approaches used herein underscore the requirement for careful anatomical refinement in CNS gene expression studies designed to understand genomic control within behaviorally-linked, but functionally isolated brain nuclei.
Clinical Chemistry | 2011
Vladimír Reiser; Ryan Smith; Jiyan Xue; Marc M. Kurtz; Rong Liu; Cheryl Legrand; Xuanmin He; Xiang Yu; Peggy Wong; John S. Hinchcliffe; Michael Tanen; Gloria Lazar; Renata Zieba; Marina Ichetovkin; Zhu Chen; Edward A. O'Neill; Wesley K. Tanaka; Matthew J. Marton; Jason Liao; Mark Morris; Eric Hailman; George Tokiwa; Andrew Plump
BACKGROUND With expanding biomarker discovery efforts and increasing costs of drug development, it is critical to maximize the value of mass-limited clinical samples. The main limitation of available methods is the inability to isolate and analyze, from a single sample, molecules requiring incompatible extraction methods. Thus, we developed a novel semiautomated method for tissue processing and tissue milling and division (TMAD). METHODS We used a SilverHawk atherectomy catheter to collect atherosclerotic plaques from patients requiring peripheral atherectomy. Tissue preservation by flash freezing was compared with immersion in RNAlater®, and tissue grinding by traditional mortar and pestle was compared with TMAD. Comparators were protein, RNA, and lipid yield and quality. Reproducibility of analyte yield from aliquots of the same tissue sample processed by TMAD was also measured. RESULTS The quantity and quality of biomarkers extracted from tissue prepared by TMAD was at least as good as that extracted from tissue stored and prepared by traditional means. TMAD enabled parallel analysis of gene expression (quantitative reverse-transcription PCR, microarray), protein composition (ELISA), and lipid content (biochemical assay) from as little as 20 mg of tissue. The mean correlation was r = 0.97 in molecular composition (RNA, protein, or lipid) between aliquots of individual samples generated by TMAD. We also demonstrated that it is feasible to use TMAD in a large-scale clinical study setting. CONCLUSIONS The TMAD methodology described here enables semiautomated, high-throughput sampling of small amounts of heterogeneous tissue specimens by multiple analytical techniques with generally improved quality of recovered biomolecules.
Assay and Drug Development Technologies | 2008
Mark Morris; Michael R. Meyer; Gary Painchaud; Jon Marlowe; George Tokiwa; Thomas L. Fare
Ultrafiltration of nucleic acids has been used for a wide variety of applications, including sequence reaction purification and amplicon cleanup prior to spotting onto microarrays. Here we describe a novel process, using ultrafiltration, that purifies cRNA products for sensitive downstream applications. Initial attempts at this high-throughput purification for cRNA resulted in low sensitivity when compared against an industry standard (silica-based bind, wash, and elute purification). We modified the ultrafiltration process to include a proteinase K preincubation and a phosphate buffer wash that, when combined, increased sensitivity and signal-to-noise ratio in microarray applications. The protocol that we have developed eliminates the use of chaotropic salts (such as guanidinium thiocyanate) that are typically used in silica binding purification methods. The data demonstrate good performance for sensitive RNA applications using well-defined metrics, and thus the technique might be useful for a broader range of nucleic acid purifications.
Analytical Chemistry | 2003
Thomas L. Fare; Ernest M. Coffey; Hongyue Dai; Yudong D. He; Deborah A. Kessler; Kristopher A. Kilian; John E. Koch; Eric M. Leproust; Matthew J. Marton; Michael R. Meyer; Roland Stoughton; George Tokiwa; Yanqun Wang
Genomics | 2005
Alessandra C. Cervino; Guoya Li; Steve Edwards; Jun Zhu; Cathy Laurie; George Tokiwa; Pek Yee Lum; Susanna Wang; Lawrence W. Castellini; Aldons J. Lusis; Sonia Carlson; Alan B. Sachs; Eric E. Schadt
Clinical Chemistry | 2008
Christopher Wright; Donald Bergstrom; Hongyue Dai; Matthew J. Marton; Mark Morris; George Tokiwa; Yanqun Wang; Thomas L. Fare
Journal of Translational Medicine | 2009
Sven Duenwald; Mingjie Zhou; Yanqun Wang; Serguei Lejnine; Amit Kulkarni; Jaime Graves; Ryan Smith; John Castle; George Tokiwa; Bernard M. Fine; Hongyue Dai; Thomas L. Fare; Matthew J. Marton
Genomics | 2009
Alessandra C. Cervino; Guoya Li; Steve Edwards; Jun Zhu; Cathy Laurie; George Tokiwa; Pek Yee Lum; Susanna Wang; Lawrence W. Castellani; Aldons J. Lusis; Sonia Carlson; Alan B. Sachs; Eric E. Schadt